Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Other 1Breast 1

Conditions

Prostatic Neoplasms 2Weight Loss 1Obesity 1Lymphedema 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Weight Reduction Programs × Clear all
NCT03261271 2025-04-13

WARRIOR

University of Kansas Medical Center

Phase NA Completed
40 enrolled 19 charts
GenitourinaryOther

Obesity, Prostatic Neoplasms

NCT04974268 2025-02-14

EJERDIETLIF

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms, Lymphedema

NCT02252484 2016-09-07

Energy Balance for Prostate Cancer Survivorship

University of Kansas Medical Center

Phase NA Completed
20 enrolled
Genitourinary

Prostatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡